259 related articles for article (PubMed ID: 27775804)
41. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
[TBL] [Abstract][Full Text] [Related]
42. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
43. Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus.
Song CM; Lee DW; Ji YB; Jeong JH; Park JH; Tae K
Head Neck; 2016 Apr; 38 Suppl 1():E412-6. PubMed ID: 25581039
[TBL] [Abstract][Full Text] [Related]
44. Tumor border pattern and size help predict lymph node status in papillary microcarcinoma: A clinicopathologic study.
Taşkın OÇ; Armutlu A; Ağcaoğlu O; Peker Ö; Terzioğlu T; Demirkol MO; Tezelman S; Kapran Y
Ann Diagn Pathol; 2020 Oct; 48():151592. PubMed ID: 32871504
[TBL] [Abstract][Full Text] [Related]
45. [The clinical significance of Delphian lymph node metastasis in papillary thyroid cancer].
Zheng GB; Hao SL; Liu XC; Ning JY; Wu GC; Wang D; Li BY; Jiang LX; Song XC; Zheng HT
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Nov; 51(11):842-845. PubMed ID: 27938611
[No Abstract] [Full Text] [Related]
46. [Clinical factors related to central compartment lymph node metastasis in papillary thyroid microcarcinoma: clinical analysis of 117 cases].
Shao Y; Cai XJ; Gao L; Li H; Xie L
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):403-5. PubMed ID: 19567120
[TBL] [Abstract][Full Text] [Related]
47. [Clinical significance of lymphatic metastasis between sternocleidomastoid and sternohyoid muscle in papillary thyroid cancer].
Hao SL; Sun HQ; Liu XC; Chen HJ; Ning JY; Zheng GB; Wu GC; Song XC; Zheng HT
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 52(10):755-759. PubMed ID: 29050093
[No Abstract] [Full Text] [Related]
48. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma.
Park JP; Roh JL; Lee JH; Baek JH; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Am J Surg; 2014 Sep; 208(3):412-8. PubMed ID: 24602323
[TBL] [Abstract][Full Text] [Related]
50. BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.
Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS
Head Neck; 2016 Apr; 38 Suppl 1():E1203-9. PubMed ID: 26268700
[TBL] [Abstract][Full Text] [Related]
51. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
Dong S; Xia Q; Wu YJ
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
[TBL] [Abstract][Full Text] [Related]
52. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
53. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
[TBL] [Abstract][Full Text] [Related]
54. The significance and prognostic value of multifocal papillary thyroid carcinoma in children and adolescents.
Sun Y; Liu Y; Li H; Tang Y; Liu W; Zhang Y; Yin D
BMC Cancer; 2024 Jun; 24(1):690. PubMed ID: 38844891
[TBL] [Abstract][Full Text] [Related]
55. Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma.
Ji YB; Lee DW; Song CM; Kim KR; Park CW; Tae K
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):542-7. PubMed ID: 24429357
[TBL] [Abstract][Full Text] [Related]
56. Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma.
Yan Y; Wang Y; Liu N; Duan Y; Chen X; Ye B; Yang R; Zhang W; Wang X
Eur J Surg Oncol; 2021 Jul; 47(7):1727-1733. PubMed ID: 33632590
[TBL] [Abstract][Full Text] [Related]
57. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.
Tang T; Li J; Zheng L; Zhang L; Shi J
Int J Surg; 2018 Jun; 54(Pt A):129-132. PubMed ID: 29723673
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
59. [Study on the correlation between BRAF(V600E) mutation and lymphatic metastases in papillary thyroid cancer staged preoperativelv as N0].
Gao Q; Zhang W; Wang N; Duan H; Zhou Y; Zhang W; Zhao D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(23):2048-52. PubMed ID: 27101676
[TBL] [Abstract][Full Text] [Related]
60. [Role of level VI lymph nodes metastasis in cervical metastasis of patients with papillary thyroid cancer].
Bian X; Chen H; Ye X; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):664-8. PubMed ID: 21055244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]